• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
    Tags Markets Investing S&P 500
    From CNBC.com News
    Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
    Tags Health care industry Dexcom Inc AI / Artificial Intelligence
    From CNBC.com News
    FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
    Tags Companies Pharmaceuticals Health care industry
    From CNBC.com News
    CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
    Tags World Markets Market Outlook Starbucks Corp
    From CNBC.com News
    FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
    Tags Companies Business Science
    From CNBC.com News
    Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
    Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
    From CNBC.com News
    Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
    Tags Merck & Co Inc AstraZeneca PLC Pharmaceuticals
    From CNBC.com News
    Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
    Tags Dassault Systemes SE Sage Group PLC BE Semiconductor Industries NV
    From CNBC.com News
    Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
    Tags Novo Nordisk A/S Healthy Returns Biotech and Pharmaceuticals
    From CNBC.com News
    Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
    Tags Health care industry Health & Science Roche Holding AG
    From CNBC.com News
    Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
    Tags Health & Science LILLY DRN US: News
    From CNBC.com News
    The weight-loss drug boom has become one of the internet's biggest scams
    Tags Health care industry Pharmaceuticals Social media
    From CNBC.com News
    Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
    Tags Amgen Inc AstraZeneca PLC LILLY DRN
    From CNBC.com News
    Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
    Tags Health & Science US: News Social issues
    From CNBC.com News
    Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
    Tags Microstrategy Inc Novo Nordisk A/S NVIDIA Corp
    From CNBC.com News
    Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
    Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
    From CNBC.com News
    5 things to know before the stock market opens Tuesday
    Tags Best Buy Co Inc Economy Novo Nordisk A/S
    From CNBC.com News
    Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
    Tags Amgen Inc Biotechnology Breaking News: Business
    From CNBC.com News
    Amgen stock falls as analysts mull over weight loss drug’s bone density data
    Tags Business News Novo Nordisk A/S Biotech and Pharmaceuticals
    From CNBC.com News
    Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
    Tags Health care industry Health & Science Viking Therapeutics Inc
    From CNBC.com News
    Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
    Tags Social issues Health care industry UnitedHealth Group Inc
    From CNBC.com News
    Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
    Tags Breaking News: Business Biotechnology LILLY DRN
    From CNBC.com News
    Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
    Tags Medical research Health & Science Obesity
    From CNBC.com News
    Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
    Tickers HIMS LLY NEWS NVO
    Tags semaglutide Food and Drug Administration NVO
    From Benzinga
    Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
    Tags Social issues LILLY DRN Microsoft Corp
    From CNBC.com News
    Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
    Tags Companies Health care industry Pharmaceuticals
    From CNBC.com News
    Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
    Tags Biotech and Pharmaceuticals Healthy Returns Novo Nordisk A/S
    From CNBC.com News
    Cramer's Lightning Round: Uranium Energy is 'the real deal'
    Tags Market Outlook stocks Halliburton Co
    From CNBC.com News
    Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
    Tags Pharmaceuticals Zealand Pharma A/S Europe News
    From CNBC.com News
    Ozempic underworld: Inside the black market of obesity drugs
    Tags World News CNBC Investigations Novo Nordisk A/S
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.